Timing of Acute Myocardial Infarction in Patients Undergoing Total Hip or Knee Replacement A Nationwide Cohort Study

被引:64
|
作者
Lalmohamed, Arief [1 ]
Vestergaard, Peter [2 ]
Klop, Corinne [1 ]
Grove, Erik Lerkevang [3 ]
de Boer, Anthonius [1 ]
Leufkens, Hubertus G. M. [1 ]
van Staa, Tjeerd P. [1 ,4 ]
de Vries, Frank [1 ,4 ,5 ]
机构
[1] Univ Utrecht, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht Inst Pharmaceut Sci, NL-3508 TB Utrecht, Netherlands
[2] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, DK-8000 Aarhus, Denmark
[3] Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark
[4] Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton SO9 4XY, Hants, England
[5] Maastricht Univ, Dept Clin Pharm & Toxicol, Med Ctr, Maastricht, Netherlands
关键词
RISK-FACTORS; MORTALITY; EPIDEMIOLOGY; ARTHROPLASTY; COMPLICATIONS; NSAIDS;
D O I
10.1001/archinternmed.2012.2713
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Limited evidence suggests that the risk of acute myocardial infarction (AMI) may be increased shortly after total hip replacement (THR) and total knee replacement (TKR) surgery. However, risk of AMI in these patients has not been compared against matched controls who have not undergone surgery. The objective of this study was to evaluate the timing of AMI in patients undergoing THR or TKR surgery compared with matched controls. Methods: Retrospective, nationwide cohort study within the Danish national registries. All patients who underwent a primary THR or TKR (n=95 227) surgery from January 1, 1998, through December 31, 2007, were selected and matched to 3 controls (no THR or TKR) by age, sex, and geographic region. All study participants were followed up for AMI, and disease- and medication history adjusted hazard ratios (HRs) were calculated. Results: During the first 2 postoperative weeks, the risk of AMI was substantially increased in THR patients compared with controls (adjusted HR, 25.5; 95% CI, 17.1-37.9). The risk remained elevated for 2 to 6 weeks after surgery (adjusted HR, 5.05; 95% CI, 3.58-7.13) and then decreased to baseline levels. For TKR patients, AMI risk was also increased during the first 2 weeks (adjusted HR, 30.9; 95% CI, 11.1-85.5) but did not differ from controls after the first 2 weeks. The absolute 6-week risk of AMI was 0.51% in THR patients and 0.21% in TKR patients. Conclusions: Risk of AMI is substantially increased in the first 2 weeks after THR (25-fold) and TKR (31-fold) surgery compared with controls. Risk assessment of AMI should be considered during the first 6 weeks after THR surgery and during the first 2 weeks after TKR surgery.
引用
收藏
页码:1229 / 1235
页数:7
相关论文
共 50 条
  • [31] RECOVER-E - a mobile app for patients undergoing total knee or hip replacement: study protocol
    Stauber, Anja
    Schuessler, Nadine
    Palmdorf, Sarah
    Schuerholz, Nina
    Bruns, David
    Osterbrink, Juergen
    Nestler, Nadja
    BMC MUSCULOSKELETAL DISORDERS, 2020, 21 (01)
  • [32] Total knee and hip replacement for patients with hemophilia
    Zorenko, V. J.
    Karpov, E. E.
    Polyanskaya, T. J.
    HAEMOPHILIA, 2008, 14 : 81 - 81
  • [33] Incidence of post-operative acute myocardial infarction among adults undergoing elective spinal fusion, Total hip and Total knee arthroplasty
    Huang, Kui
    Arena, Patrick
    Zhou, Xiaofeng
    Liu, Qing
    Gong, Richard
    Murugesan, Sundaresan
    Mo, Jingping
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 86 - 86
  • [34] Thromboprophylaxis in patients undergoing total hip replacement
    Brenkel, IJ
    Cook, RE
    HOSPITAL MEDICINE, 2003, 64 (05): : 281 - 287
  • [35] Clinical and cost outcomes of venous thromboembolism in Medicare patients undergoing total hip replacement or total knee replacement surgery
    Baser, Onur
    Supina, Dylan
    Sengupta, Nishan
    Wang, Li
    Kwong, Louis
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (02) : 423 - 429
  • [36] Effectiveness of psychological support in patients undergoing primary total hip or knee arthroplasty: a controlled cohort study
    Tristaino V.
    Lantieri F.
    Tornago S.
    Gramazio M.
    Carriere E.
    Camera A.
    Journal of Orthopaedics and Traumatology, 2016, 17 (2) : 137 - 147
  • [37] Safety and efficacy of a new thromboprophylaxis regiment for total knee and total hip replacement: A retrospective cohort study in 265 patients
    Fallaha M.A.
    Radha S.
    Patel S.
    Patient Safety in Surgery, 12 (1)
  • [38] Population Pharmacokinetics of Periarticular Ketorolac in Adult Patients Undergoing Total Hip or Total Knee Replacement Surgery
    Gurunathan, Usha
    Parker, Suzanne L.
    Maguire, Richard
    Ramdath, Dale
    Bijoor, Manu
    Wallis, Steven C.
    Roberts, Jason A.
    ANESTHESIA AND ANALGESIA, 2019, 129 (03): : 701 - 708
  • [39] Evidence based venous thromboprophylaxis in patients undergoing total hip replacement (THR), total knee replacement (TKR) and hip fracture surgery (HFS)
    Autar, Ricky
    INTERNATIONAL JOURNAL OF ORTHOPAEDIC AND TRAUMA NURSING, 2011, 15 (03) : 145 - 154
  • [40] Impact of venous thromboemolism in US Medicare patients undergoing total hip and total knee replacement surgery
    Baser, O.
    Supina, D.
    Sengupta, N.
    Wang, L.
    Kwong, L. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 788 - 789